Malvern company testing its depression treatment in women with postpartum symptoms – Philadelphia Business Journal.
New non-drug help for postpartum depression?
Neuronetics has started testing to see if its non-drug depression treatment can also help women who are experiencing postpartum symptoms.
The clinical trials involving the new application for the Malvern, Pa., company’s NeuroStar Transcranial Magnetic Stimulation device began this week and are taking place at sites across the country including the University of Pennsylvania in Philadelphia.
Postpartum depression affects one in seven new mothers and is the most common complication of child birth, according to health officials. Many women suffering from postpartum, particularly those who are breastfeeding, may hesitate to seek treatment with oral medications given the potential side effects.
Neuronetics’ NeuroStar TMS Therapy System was cleared by the Food and Drug Administration in October 2008 for the treatment of major depressive disorder. The therapy delivers highly-focused MRI-strength magnetic field pulses designed to stimulate nerve cells in an area of the brain that has been linked to depression.